Food, Beverage & Tobacco Healthcare Sector

TransMedics Group

Market Cap: US$4.2b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Krystal Biotech

Market Cap: US$4.2b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

ADMA Biologics

Market Cap: US$4.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

TG Therapeutics

Market Cap: US$4.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Kindly MD

Market Cap: US$4.0b

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

Arcellx

Market Cap: US$4.0b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Zai Lab

Market Cap: US$3.9b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

PTC Therapeutics

Market Cap: US$3.9b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Chartwell Retirement Residences

Market Cap: CA$5.4b

Chartwell is in the business of serving and caring for Canada’s seniors, committed to its vision of Making People’s Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents.

Akero Therapeutics

Market Cap: US$3.8b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Lantheus Holdings

Market Cap: US$3.7b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Integer Holdings

Market Cap: US$3.7b

Operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally.

Telix Pharmaceuticals

Market Cap: AU$5.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Soleno Therapeutics

Market Cap: US$3.6b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Protagonist Therapeutics

Market Cap: US$3.5b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

GeneDx Holdings

Market Cap: US$3.5b

A genomics company, provides genetic testing services.

Envista Holdings

Market Cap: US$3.4b

Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.

1Life Healthcare

Market Cap: US$3.4b

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.

Apellis Pharmaceuticals

Market Cap: US$3.4b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

MoonLake Immunotherapeutics

Market Cap: US$3.3b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Metsera

Market Cap: US$3.3b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

SYNLAB

Market Cap: €2.8b

Provides medical diagnostic services and specialty testing services in Europe.

Mirum Pharmaceuticals

Market Cap: US$3.3b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Perrigo

Market Cap: US$3.2b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Prestige Consumer Healthcare

Market Cap: US$3.2b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Jyong Biotech

Market Cap: US$3.1b

A science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

ICU Medical

Market Cap: US$3.1b

Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.

Kymera Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Ligand Pharmaceuticals

Market Cap: US$3.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Surgery Partners

Market Cap: US$3.0b

Owns and operates a network of surgical facilities and ancillary services in the United States.

Alignment Healthcare

Market Cap: US$3.0b

Operates a consumer-centric healthcare platform for seniors in the United States.

Concentra Group Holdings Parent

Market Cap: US$2.9b

Provides occupational health services in the United States.

Amneal Pharmaceuticals

Market Cap: US$2.9b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Indivior

Market Cap: US$2.9b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Ansell

Market Cap: AU$4.5b

Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.